Literature DB >> 1602047

Age and Pap smear history as a basis for intervention strategy.

C Spurlock1, M Nadel, E McManmon.   

Abstract

As a means of developing effective intervention strategies for promoting Pap smear screening, we analyzed data from a population-based women's health survey (N = 603) in a 36-county area in southeastern Kentucky. The cervical cancer mortality rate for white women in this area is one of the highest in the United States. By using selected sociodemographic, health-care utilization, health knowledge, and health behavior variables in age-specific logistic regression models, we discriminated between women who had had a Pap smear within 3.5 years and those who had not. Several variables predicted Pap screening status regardless of the woman's age. Women of all age groups who had not been recently screened had encounters with the medical-care system. A key variable that affected use of screening services was ever use of birth control pills. The main differences between the three age groups were as follows: the 18-44 age group was less likely to see a private physician and less likely to seek medical care of any type, except for care related to pregnancy; only the 45-59 age group believed that cost of medical care was a problem; and only for the 60 or older age group were socioeconomic variables associated with not having recently had a Pap test.

Entities:  

Mesh:

Year:  1992        PMID: 1602047     DOI: 10.1007/bf01321578

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  10 in total

1.  Site-specific cancer mortality among Kentucky residents, 1971-1985.

Authors:  C W Spurlock
Journal:  J Ky Med Assoc       Date:  1988-02

2.  From the Centers for Disease Control. Black-white differences in cervical cancer mortality--United States, 1980-1987.

Authors: 
Journal:  JAMA       Date:  1990-06-13       Impact factor: 56.272

3.  Control of cervix cancer in women of low income in a community.

Authors:  W M Christopherson; J E Parker
Journal:  Cancer       Date:  1969-07       Impact factor: 6.860

4.  Cervical cancer mortality trends in Kentucky, 1971-83.

Authors:  M W Hinds; J W Skaggs; C Hernandez
Journal:  J Ky Med Assoc       Date:  1985-04

5.  Screening for cervical and breast cancer--southeastern Kentucky.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1988-01-08       Impact factor: 17.586

6.  Descriptive epidemiology of cancer of the uterine cervix.

Authors:  S S Devesa
Journal:  Obstet Gynecol       Date:  1984-05       Impact factor: 7.661

7.  Does screening by "Pap" smears help prevent cervical cancer? A case-control study.

Authors:  E A Clarke; T W Anderson
Journal:  Lancet       Date:  1979-07-07       Impact factor: 79.321

8.  Efficacy of screening for cervical cancer: a review.

Authors:  D S Guzick
Journal:  Am J Public Health       Date:  1978-02       Impact factor: 9.308

9.  A case-control study of cervical cancer screening in north east Scotland.

Authors:  J E Macgregor; S M Moss; D M Parkin; N E Day
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-25

10.  Cervical cancer screening practices among older women: results from the Maryland Cervical Cancer Case-Control Study.

Authors:  D D Celentano; A C Klassen; C S Weisman; N B Rosenshein
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

  10 in total
  3 in total

1.  Health care utilization among drug-using and non-drug-using women.

Authors:  Claire E Sterk; Katherine P Theall; Kirk W Elifson
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

2.  Non-utilization of the Pap Test Among Women with Frequent Health System Contact.

Authors:  Abayomi N Ogunwale; Haleh Sangi-Haghpeykar; Jane Montealegre; Yiwen Cui; Maria Jibaja-Weiss; Matthew L Anderson
Journal:  J Immigr Minor Health       Date:  2016-12

3.  Mammography and pap smear use by older rural women.

Authors:  D G Ives; J R Lave; N D Traven; R Schulz; L H Kuller
Journal:  Public Health Rep       Date:  1996 May-Jun       Impact factor: 2.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.